Renal cell cancer: causes, prognosis, management and treatments
Jane Boxall Research nurse in medical oncology (renal cell cancer and metastatic melanoma), Mount Vernon Hospital, Middlesex
Paul Nathan Consultant medical oncologist, Department of Medical Oncology, Mount Vernon Hospital, Middlesex
Most patients who develop renal cell or kidney cancer can be treated with a radical nephrectomy. However, for those who present with metastatic disease, the therapeutic options are limited to interferon and interleukin-2. Response rates to these cytokine treatments range from 10 to 20 per cent but the drugs carry substantial toxicity. This article discusses the new biological agents currently in development for the treatment of kidney cancer.
Cancer Nursing Practice. 5, 3,29-33. doi: 10.7748/cnp2006.04.5.3.29.c181